Ryght AI Welcomes the Medical College of Wisconsin to Global Site Network As Their Latest Academic Partner

Membership will bolster the ranks of academic and community hospitals joining the Ryght Research Network to streamline clinical trials with AI

LAGUNA BEACH, Calif., April 3, 2025 /PRNewswire/ -- Ryght, a pioneer in real-time generative AI healthcare technology for the clinical research industry, today announced the addition of the Medical College of Wisconsin (MCW) to its rapidly expanding "Ryght Research Network." MCW's membership in this global network of clinical research sites, which includes thousands of prestigious academic institutions and community sites around the world, further strengthens Ryght's mission to revolutionize clinical trials by providing sponsors and CROs with a real-time, global, AI-connected network to optimize the accuracy and speed of site activation, patient enrollment and trial compliance.

The Medical College of Wisconsin has a long-standing reputation for excellence in medical education, research, and patient care. By joining the Ryght Research network, MCW is poised to enhance its impact globally and continue its rooted tradition of improving the outcomes of patients with cancer. As the only academic cancer center in its area, MCW serves large, medically underserved populations who may experience disparities in access to clinical trials. Partnering with Ryght allows better access to all patients in need of clinical trials and life-saving therapies. With hundreds of clinical trials and principal investigators dedicated to bringing innovative therapies to patients, MCW's partnership is destined to enhance the network's capabilities of revolutionizing how cancer clinical research is conducted. This collaboration aims to address critical challenges in clinical trials, such as staff burnout, administrative inefficiencies, patient enrollment difficulties, and long cancer drug development timelines.

"Joining the Ryght Research Network affirms our commitment to advancing cancer research. Ryght's cutting-edge AI technology has the potential to transform clinical trial operations," said Mary Horowitz, MD, MS, Professor of Hematologic Research and Deputy Cancer Center Director at the Medical College of Wisconsin. "We look forward to accelerating the development of potentially life-saving therapies to bring the right studies to the patients we serve."

"Our institution is excited to join the Ryght Research Network. Bringing AI to how we execute and conduct clinical trials positions us at the forefront of innovation and technology," said Ben George, MD, Professor of Medicine and Associate Director of Experimental Therapeutics at the Medical College of Wisconsin.

The Ryght Research Network leverages advanced generative- and agentic-AI capabilities to process site-specific and industry-wide data, delivering real-time insights that empower sites, sponsors and CROs to make data-driven decisions, faster. By automating crucial tasks such as site identification, site feasibility and selection, budget negotiations, patient referrals and trial compliance, the network transforms traditional trial workflows, simplifying trial management for research sites and accelerating ideal site and patient selection for sponsors and their CROs.

"We are thrilled to welcome the Medical College of Wisconsin into our growing, global Ryght Research Network." said Chadi Nabhan, MD, MBA, FACP, Chief Medical Officer and Head of Strategy at Ryght AI. "I know first-hand that their mission and vision are aligned with our goals of breaking barriers to clinical trial access. Together, we will expedite trial processes and improve outcomes for cancer patients through the innovative application of AI technology." Nabhan continued.

About Ryght:
Ryght AI, the real-time clinical trials company, is a privately held healthcare technology company providing next-generation safe and secure generative artificial intelligence (GenAI) solutions for the clinical research industry. Ryght's SOC Type 2-compliant platform and customized research applications streamline clinical trials, accelerate workflows, and provide real-time communication for trial sites, sponsors, and CROs. Ryght's base applications are free of charge to research sites globally.

For more information, please visit www.ryght.ai. To discuss AI-powered clinical trial solutions or network membership for your site, CRO or biopharma company, please email [email protected].

About the Medical College of Wisconsin: 
With a history dating back to 1893, The Medical College of Wisconsin is dedicated to leadership and excellence in education, patient care, research, and community engagement. More than 1,500 students are enrolled in MCW's medical school and graduate school programs in Milwaukee, Green Bay, and Central Wisconsin. MCW's School of Pharmacy opened in 2017. A major national research center, MCW is the largest research institution in the Milwaukee metro area and second largest in Wisconsin. In the last 10 years, faculty received more than $1.5 billion in external support for research, teaching, training, and related purposes. This total includes highly competitive research and training awards from the National Institutes of Health (NIH). Annually, MCW faculty direct or collaborate on more than 3,100 research studies, including clinical trials. Additionally, more than 1,650 physicians provide care in virtually every specialty of medicine for more than 2.8 million patients annually. Learn more at www.mcw.edu.

Media Contact:

Alexia Krispin
[email protected]

SOURCE Ryght